NCT01249456View on ClinicalTrials.gov

Safety and Efficacy Study of Femara(Letrozole) as an Extended Adjuvant Treatment in Breast Cancer Patients

CompletedOBSERVATIONAL
Enrollment

392

Participants

Timeline

Start Date

May 31, 2006

Primary Completion Date

April 30, 2015

Study Completion Date

April 30, 2015

Conditions
Breast CancerLetrozole
Trial Locations (1)

Unknown

Samsung Medical Center, Seoul

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY